Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,576
Closed -$288K 652
2021
Q4
$288K Sell
4,576
-2,479
-35% -$210K 0.11% 232
2021
Q3
$744K Buy
7,055
+6,182
+708% +$888K 0.19% 148
2021
Q2
$155K Sell
873
-3,232
-79% -$520K 0.03% 493
2021
Q1
$548K Buy
4,105
+3,939
+2,373% +$610K 0.18% 139
2020
Q4
$22K Buy
+166
New +$16.9K ﹤0.01% 865
2020
Q3
Sell
-3,205
Closed -$263K 1037
2020
Q2
$263K Buy
3,205
+2,670
+499% +$181K 0.09% 288
2020
Q1
$28K Sell
535
-1,239
-70% -$64.6K 0.01% 900
2019
Q4
$74K Buy
+1,774
New +$65.5K 0.01% 814

Other funds holding ZLAB

FORA Capital's ZLAB Position: Q1 2022 in Review

FORA Capital sold out of Zai Lab (ZLAB) in Q1 2022, closing a stake of 4,576 shares — an estimated $288K sold.

FORA Capital first reported a position in ZLAB in Q4 2019 and held it in 8 quarters. The position peaked at $744K in Q3 2021. 175 funds tracked by Wall St. Rank hold ZLAB as of Q1 2022.

  • FORA Capital reported no remaining Zai Lab position as of Q1 2022 after selling out during the quarter.
  • FORA Capital sold 4,576 Zai Lab shares in Q1 2022, an estimated $288K.
  • FORA Capital first reported a position in Zai Lab in Q4 2019 and held it in 8 quarters.
  • FORA Capital's Zai Lab position peaked at $744K in Q3 2021.
  • 175 funds tracked by Wall St. Rank held Zai Lab as of Q1 2022.

Based on FORA Capital's 13F filing for Q1 2022, filed 12 May 2022.